Skip to Main Content

Author Details

Christopher S Foster
The Institute of Cancer Research
1978
196
55
PMIDPaper TitleJournal TitlePublished Year
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
31411968A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.Eur Urol Oncol2020
30894674Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.Prostate Cancer Prostatic Dis2019
31537406Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.Eur Urol2019
29301143Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29509747Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
28768264Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.Urol Int2017
28408174Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.Eur Urol2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28698647Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Sci Rep2017
28698102Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer.Pathol Res Pract2017
27197245Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.Genome Res2016
27708246A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.Oncotarget2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25830880The evolutionary history of lethal metastatic prostate cancer.Nature2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25963125Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.Genome Res2015
24189640The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.Int J Oncol2014
25193387DNA methylation gene-based models indicating independent poor outcome in prostate cancer.BMC Cancer2014
25271376Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.Elife2014
25402584DNA methylation of PITX2 predicts poor survival in men with prostate cancer.Biomark Med2014
25082706Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.Science2014
24484606Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.Eur Urol2014
24481405Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.Br J Cancer2014
23165430Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.Prostate Cancer Prostatic Dis2013
24167657A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.Genes Cancer2013
22361632Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.Br J Cancer2012
22710313Mantle cell lymphoma involving the prostate with features of granulomatous prostatitis: a case report.Int J Surg Pathol2012
22644296Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.Br J Cancer2012
20658531Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively.Int J Cancer2011
22014055Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).Histopathology2011
21799931siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.PLoS One2011
21290088Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression.Int J Oncol2011
21310658Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.Lancet Oncol2011
20840664Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.BJU Int2011
20834240An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.Mod Pathol2011
20824351Pathology: coming in from the cold.Cell Tissue Bank2011
20043088Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers.Oncol Rep2010
21779455PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.Genes Cancer2010
20827488Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.Virchows Arch2010
20854069Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.Pathology2010
20448665Molecular origin of plasma membrane citrate transporter in human prostate epithelial cells.EMBO Rep2010
20664928Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression.Int J Oncol2010
20177423The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.Prostate Cancer Prostatic Dis2010
19956834Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.Int J Oncol2010
20104229Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.Br J Cancer2010
20103652SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.Cancer Res2010
19002169Concepts of epigenetics in prostate cancer development.Br J Cancer2009
  • 1 - 50 of 196

Recommended Authors

Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 6
David Clouston
Career Start Year 1995
Number of shared co-authors 8
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 23
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 4
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 2
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 3
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 12
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 5
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 3
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 7
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 18
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 3
Dean A Troyer
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 2
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 7
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 9
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 13
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 5
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 12
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 4
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 12
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 5
Simone Chevalier
McGill University Health Centre, McGill University
Career Start Year 1977
Number of shared co-authors 7
Ralph Buttyan
University of British Columbia
Career Start Year 1976
Number of shared co-authors 4
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 9
Robert L Vessella
University of Washington
Career Start Year 1974
Number of shared co-authors 12
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Christer Busch
Uppsala University
Career Start Year 1970
Number of shared co-authors 4

Collaborators

Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 34
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 31
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 24
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 16
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 15
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 14
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 12
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 11
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 10
Elizabeth Bancroft
The Institute of Cancer Research
Co-authored papers 10
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 9
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Freddie C Hamdy
University of Oxford
Co-authored papers 8
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 8
Penny Flohr
The Institute of Cancer Research
Co-authored papers 8
Douglas F Easton
University of Cambridge
Co-authored papers 8
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 7
Sue Merson
Institute of Cancer Research
Co-authored papers 7
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 7
Andy G Lynch
University of St Andrews
Co-authored papers 7
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 7
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 7
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 7
Adam Butler
Wellcome Sanger Institute
Co-authored papers 7
Charlie E Massie
University of Cambridge
Co-authored papers 7
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 7
Hayley C Whitaker
University College London
Co-authored papers 7
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 7
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 6
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers 6
Release 1.2